Clinical Trial Update: Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Phase 1]

View source ↗

Summary

A phase 1 study evaluating the addition of everolimus to combined hormonal therapy and radiation for high-risk prostate cancer was terminated. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED | Results posted: 2014-11-20